4-Cholesten-3-one

4-Cholesten-3-one is a lipid of Sterol Lipids (ST) class. 4-cholesten-3-one is associated with abnormalities such as Dehydration, Xanthomatosis, Cerebrotendinous, Peripheral Neuropathy, L.mexicana and Xanthoma. The involved functions are known as CYP27A1activity, 25-hydroxycholesterol 7alpha-hydroxylase activity, Biochemical Pathway, Anabolism and Oxidation. 4-cholesten-3-one often locates in Mitochondria, Liver, Body tissue, Hepatic, Mitochondria and Endothelium of artery. The associated genes with 4-Cholesten-3-one are P4HTM gene, tryptones and Regulon. The related lipids are Cholestenones, 7-hydroxy-4-cholesten-3-one, cholest-4-en-3-one, 25-hydroxycholesterol and 24-hydroxycholesterol.

Cross Reference

Introduction

To understand associated biological information of 4-Cholesten-3-one, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 4-Cholesten-3-one?

4-Cholesten-3-one is suspected in Dehydration, Xanthomatosis, Cerebrotendinous, Peripheral Neuropathy, L.mexicana, Xanthoma, Rare Diseases and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

No disease MeSH terms mapped to the current reference collection.

PubChem Associated disorders and diseases

What pathways are associated with 4-Cholesten-3-one

Lipid pathways are not clear in current pathway databases. We organized associated pathways with 4-Cholesten-3-one through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 4-Cholesten-3-one?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 4-Cholesten-3-one?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 4-Cholesten-3-one?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 4-Cholesten-3-one?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 4-Cholesten-3-one?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 4-Cholesten-3-one

Download all related citations
Per page 10 20 50 100 | Total 397
Authors Title Published Journal PubMed Link
Sampson NS Dissection of a flavoenzyme active site: the reaction catalyzed by cholesterol oxidase. 2001 Antioxid. Redox Signal. pmid:11761331
Samy TS et al. Divergent immune responses in male and female mice after trauma-hemorrhage: dimorphic alterations in T lymphocyte steroidogenic enzyme activities. 2001 Endocrinology pmid:11459798
Asada Y et al. 5 alpha-reductase type 2 is constitutively expressed in the dermal papilla and connective tissue sheath of the hair follicle in vivo but not during culture in vitro. 2001 J. Clin. Endocrinol. Metab. pmid:11397903
Charbonneau A and The VL Genomic organization of a human 5beta-reductase and its pseudogene and substrate selectivity of the expressed enzyme. 2001 Biochim. Biophys. Acta pmid:11342103
DellaGreca M et al. Solid-state photodimerization of cholest-4-en-3-one. 2001 J. Org. Chem. pmid:11300900
Platz EA Basic Science. 2001 Urology pmid:11273573
Nam RK et al. V89L polymorphism of type-2, 5-alpha reductase enzyme gene predicts prostate cancer presence and progression. 2001 Urology pmid:11164181
Melcangi RC and Panzica G Steroids in the nervous system: a Pandora's box? 2001 Trends Neurosci. pmid:11421230
Haigh WG and Lee SP Identification of oxysterols in human bile and pigment gallstones. 2001 Gastroenterology pmid:11438500
Fritsch M et al. Sebocytes are the key regulators of androgen homeostasis in human skin. 2001 J. Invest. Dermatol. pmid:11348472
Shaw JC Hormonal therapies in acne. 2002 Expert Opin Pharmacother pmid:12083987
Yin Y et al. Construction of a catalytically inactive cholesterol oxidase mutant: investigation of the interplay between active site-residues glutamate 361 and histidine 447. 2002 Arch. Biochem. Biophys. pmid:12051668
Huynh H Induction of apoptosis in rat ventral prostate by finasteride is associated with alteration in MAP kinase pathways and Bcl-2 related family of proteins. 2002 Int. J. Oncol. pmid:12012013
Itoh K et al. Mutation screening for the 5alpha-reductase type 2 gene in Japanese men with idiopathic azoospermia. 2002 Fertil. Steril. pmid:12009375
Brady BM and Anderson RA Advances in male contraception. 2002 Expert Opin Investig Drugs pmid:11866663
Malik V and Pundir CS Determination of total cholesterol in serum by cholesterol esterase and cholesterol oxidase immobilized and co-immobilized on to arylamine glass. 2002 Biotechnol. Appl. Biochem. pmid:12074697
Wolfreys AM and Hepburn PA Safety evaluation of phytosterol esters. Part 7. Assessment of mutagenic activity of phytosterols, phytosterol esters and the cholesterol derivative, 4-cholesten-3-one. 2002 Food Chem. Toxicol. pmid:11893405
Hiort O et al. A novel homozygous disruptive mutation in the SRD5A2-gene in a partially virilized patient with 5alpha-reductase deficiency. 2002 Int. J. Androl. pmid:11869378
Silfen ME et al. 5 alpha-reductase and 11 beta-hydroxysteroid dehydrogenase activity in prepubertal Hispanic girls with premature adrenarche. 2002 J. Clin. Endocrinol. Metab. pmid:12364451
Nguyen DH and Taub D Cholesterol is essential for macrophage inflammatory protein 1 beta binding and conformational integrity of CC chemokine receptor 5. 2002 Blood pmid:12036855
Azzouzi AR et al. Impact of constitutional genetic variation in androgen/oestrogen-regulating genes on age-related changes in human prostate. 2002 Eur. J. Endocrinol. pmid:12370109
Yang C et al. A49T, V89L and TA repeat polymorphisms of steroid 5alpha-reductase type II and breast cancer risk in Japanese women. 2002 Breast Cancer Res. pmid:12100746
Sojo MM et al. Rhodococcus erythropolis ATCC 25544 as a suitable source of cholesterol oxidase: cell-linked and extracellular enzyme synthesis, purification and concentration. 2002 BMC Biotechnol. pmid:11914155
Ribeiro ML et al. Allelic frequencies of six polymorphic markers for risk of prostate cancer. 2002 Braz. J. Med. Biol. Res. pmid:11847524
Schatzl G et al. Association of polymorphisms within androgen receptor, 5alpha-reductase, and PSA genes with prostate volume, clinical parameters, and endocrine status in elderly men. 2002 Prostate pmid:12111704
Raynaud JP et al. Inhibition of type 1 and type 2 5alpha-reductase activity by free fatty acids, active ingredients of Permixon. 2002 J. Steroid Biochem. Mol. Biol. pmid:12477490
Carmina E Anti-androgens for the treatment of hirsutism. 2002 Expert Opin Investig Drugs pmid:11866665
Maeda Y et al. A simple, accurate, and sensitive assay method of dehydroepiandrosterone sulfate: application for quantitative determination in human breast cyst and duct fluids. 2002 Steroids pmid:11958788
Campbell SM et al. Virion-associated cholesterol is critical for the maintenance of HIV-1 structure and infectivity. 2002 AIDS pmid:12441796
Prager N et al. A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitors of 5-alpha-reductase in the treatment of androgenetic alopecia. 2002 J Altern Complement Med pmid:12006122
Pham H and Ziboh VA 5 alpha-reductase-catalyzed conversion of testosterone to dihydrotestosterone is increased in prostatic adenocarcinoma cells: suppression by 15-lipoxygenase metabolites of gamma-linolenic and eicosapentaenoic acids. 2002 J. Steroid Biochem. Mol. Biol. pmid:12589947
Zeigler-Johnson CM et al. Ethnic differences in the frequency of prostate cancer susceptibility alleles at SRD5A2 and CYP3A4. 2002 Hum. Hered. pmid:12446983
Shibata A et al. Polymorphisms in the androgen receptor and type II 5 alpha-reductase genes and prostate cancer prognosis. 2002 Prostate pmid:12210487
Suzuki Y et al. 5Alpha-reductase type 2 genes in Japanese males do not appear to be associated with cryptorchidism. 2002 Fertil. Steril. pmid:12137870
Lemonde HA et al. Mutations in SRD5B1 (AKR1D1), the gene encoding delta(4)-3-oxosteroid 5beta-reductase, in hepatitis and liver failure in infancy. 2003 Gut pmid:12970144
Nguyen PN et al. Changes in 5alpha-pregnane steroids and neurosteroidogenic enzyme expression in the perinatal sheep. 2003 Pediatr. Res. pmid:12646725
Nguyen DH and Taub DD Inhibition of chemokine receptor function by membrane cholesterol oxidation. 2003 Exp. Cell Res. pmid:14597406
Mazen I et al. Molecular analysis of 5alpha-reductase type 2 gene in eight unrelated egyptian children with suspected 5alpha-reductase deficiency: prevalence of the G34R mutation. 2003 Clin. Endocrinol. (Oxf) pmid:12699446
Sung YM et al. Re: Hormonal markers and hepatitis B virus-related hepatocellular carcinoma risk: a nested case-control study among men. 2003 J. Natl. Cancer Inst. pmid:12671025
Norlin M et al. On the substrate specificity of human CYP27A1: implications for bile acid and cholestanol formation. 2003 J. Lipid Res. pmid:12777473
Liu XC and Kayser L New approach to regioselective synthesis: using proteins in vitro as guidance-regioselective reduction of steroids with guidance from bovine serum albumin. 2003 Biotechnol. Bioeng. pmid:12701153
Martin RM et al. Familial hyperestrogenism in both sexes: clinical, hormonal, and molecular studies of two siblings. 2003 J. Clin. Endocrinol. Metab. pmid:12843139
Johnson DC and Widlanski TS Cerium(III) chloride-mediated reactions of sulfonamide dianions. 2003 J. Org. Chem. pmid:12816492
Ji Q et al. Selective reduction of AKR1C2 in prostate cancer and its role in DHT metabolism. 2003 Prostate pmid:12539226
Fassnacht M et al. Beyond adrenal and ovarian androgen generation: Increased peripheral 5 alpha-reductase activity in women with polycystic ovary syndrome. 2003 J. Clin. Endocrinol. Metab. pmid:12788885
Yoshida T et al. Origin of oxysterols in hepatic bile of patients with biliary infection. 2003 Am. J. Gastroenterol. pmid:14572579
Sasaki G et al. Micropenis and the 5alpha-reductase-2 (SRD5A2) gene: mutation and V89L polymorphism analysis in 81 Japanese patients. 2003 J. Clin. Endocrinol. Metab. pmid:12843198
Faragalla J et al. Comparative pharmacophore development for inhibitors of human and rat 5-alpha-reductase. 2003 J. Mol. Graph. Model. pmid:12798393
Li Z et al. Association of V89L SRD5A2 polymorphism with prostate cancer development in a Japanese population. 2003 J. Urol. pmid:12771801
Chang BL et al. Evaluation of SRD5A2 sequence variants in susceptibility to hereditary and sporadic prostate cancer. 2003 Prostate pmid:12746845